Tanner Laura, Vainio Paula, Sandell Minna, Laine Jukka
1 Department of Clinical Genetics, Turku University Hospital, Turku, Finland.
2 Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland.
Pediatr Dev Pathol. 2017 Sep-Oct;20(5):455-459. doi: 10.1177/1093526616686903. Epub 2017 Jan 25.
Osteogenesis imperfecta is a genetically and clinically heterogenous group of skeletal dysplasias characterized by bone fragility. Its severity ranges from nearly asymptomatic individuals to perinatal lethality. The majority of cases are caused by mutations in either the COL1A1 or the COL1A2 gene coding for alpha 1 and alpha 2 chains of collagen type 1, respectively, and a large number of pathogenic variants of these genes has been identified. We describe a novel COL1A1 mutation associated with prenatally diagnosed severe form of osteogenesis imperfecta.
成骨不全症是一组在遗传和临床上具有异质性的骨骼发育不良疾病,其特征为骨骼脆弱。其严重程度从几乎无症状的个体到围产期致死不等。大多数病例是由分别编码I型胶原蛋白α1链和α2链的COL1A1或COL1A2基因发生突变引起的,并且已经鉴定出这些基因的大量致病变异。我们描述了一种与产前诊断的严重形式成骨不全症相关的新型COL1A1突变。